Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011 Apr;300(4):L512-5.
doi: 10.1152/ajplung.00023.2011. Epub 2011 Feb 4.

Matrix metalloproteinases: all the RAGE in the acute respiratory distress syndrome

Anja H Hergrueter, Khoi Nguyen, Caroline A Owen
Editorial

Matrix metalloproteinases: all the RAGE in the acute respiratory distress syndrome

Anja H Hergrueter et al. Am J Physiol Lung Cell Mol Physiol. 2011 Apr.
No abstract available

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Potential impact of matrix metalloproteinase (MMP)-mediated proteolytic shedding of receptor for advanced glycation end products (RAGE) on the pathogenesis of acute respiratory distress syndrome (ARDS). Transmembrane RAGE is expressed by alveolar epithelial type I cells, and the variable domain of this receptor binds various ligands including high-mobility group box 1 (HMGB1). Binding of ligands to the ectodomain of RAGE can promote 1) lung inflammation in the acute-exudative phase of ARDS by activating NF-κB to increase the expression of proinflammatory genes and 2) fibroproliferative responses of the lung in the subacute phase of ARDS by increasing lung production of profibrotic growth factors including transforming growth factor-β (TGF-β) and platelet-derived growth factor (PDGF) and inducing epithelial-mesenchymal transition (EMT). MMP-3 and -13-mediated shedding of RAGE ectodomain releases soluble RAGE (sRAGE) forms. The latter may block pathological processes in the lungs of ARDS patients by acting as decoy receptors that bind RAGE ligands to prevent them from inducing intracellular signaling via the transmembrane form of RAGE.
See this image and copyright information in PMC

References

    1. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. HMG-1 as a mediator of acute lung inflammation. J Immunol 165: 2950–2954, 2000 - PubMed
    1. Albaiceta GM, Gutierrez-Fernandez A, Garcia-Prieto E, Puente XS, Parra D, Astudillo A, Campestre C, Cabrera S, Gonzalez-Lopez A, Fueyo A, Taboada F, Lopez-Otin C. Absence or inhibition of matrix metalloproteinase-8 decreases ventilator-induced lung injury. Am J Respir Cell Mol Biol 43: 555–563, 2010 - PubMed
    1. Albaiceta GM, Gutierrez-Fernandez A, Parra D, Astudillo A, Garcia-Prieto E, Taboada F, Fueyo A. Lack of matrix metalloproteinase-9 worsens ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 294: L535–L543, 2008 - PubMed
    1. Bastarache JA, Fremont RD, Kropski JA, Bossert FR, Ware LB. Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 297: L1035–L1041, 2009 - PMC - PubMed
    1. Briot R, Frank JA, Uchida T, Lee JW, Calfee CS, Matthay MA. Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs. Chest 135: 269–275, 2009 - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources